SEATTLE, May 10, 2021, (MEDGADGET) — Overview:
Cervical cancer develops in the cervix’s cells. Cervical cancer is diagnosed with a Pap smear, colposcopy, and the ECC examination. In emerging countries, there is a growing awareness of cervical cancer, as well as an increase in the incidence of the disease, which are expected to drive growth of the global cervical cancer diagnostic tests market over the forecast period. For instance, according to the American Cancer Society, invasive cervical cancer is expected to be diagnosed in over 13,800 new cases in the U.S. in 2020, with around 4,290 people expected to die from the condition.
*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3994
The global cervical cancer diagnostic tests market is expected to be valued around US$ 5,910.2 million in 2020 and is estimated to register a CAGR over 6.2 % during the forecast period (2020-2027).
Drivers:
Rising incidences of HPV infected patients and growing prevalence of teenage sexual encounters are expected to propel the global cervical cancer diagnostic tests market growth during the forecast period.
Human Papillomavirus (HPV) is the most common cause of cervical cancer. For instance, according to the World Health Organization, two types of HPV, HPV 16 and 18, cause around 70% of cervical cancers and pre-cancerous cervical lesions.
Moreover, according to the Centers for Disease Control and Prevention (CDC), 9 out of 10 cervical cancers are caused owing to Human Papillomavirus (HPV) and over 11,000 cases of cervical cancer are caused by Human Papillomavirus (HPV) every year in the U.S.
However, Human Papillomavirus (HPV) is primarily spread through sexual contact, and some forms of HPV obtained through sexual contact can cause cervical cancer.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3994
Furthermore, a cross-sectional, multicentric, nationwide survey was conducted between September 2016 and November 2017 in Brazil to evaluate the prevalence of HPV infection in sexually active adolescents and young adults. However, according to the survey, the mean age of first sexual intercourse was 15.3 years in women and 14.9 years in men.
Rising incidences of cervical cancer is expected to propel the global cervical cancer diagnostic tests market growth during the forecast period. For instance, according to the Cancer Research UK, over 3,152 new cases of cervical cancer were diagnosed during 2015 to 2017 in the U.K. and over 852 deaths were reported during the same time interval in the U.K.
Moreover, growing incidences of cervical cancer is expected to propel the global cervical cancer diagnostic tests market growth during the forecast period.
Impact of Coronavirus (Covid-19) Pandemic
The COVID-19 pandemic and subsequent lockdown in different countries around the world has had a financial effect on industries in all sectors. The private healthcare sector is one of the areas where the pandemic has had a significant effect.
The pandemic’s lockdown has placed a financial strain on the private healthcare system in a number of countries. Outpatient visits, staffing, supplies, consumables, and other services are all decreasing, making it difficult for healthcare providers to ensure the protection of patients with other diseases.
Furthermore, the coronavirus pandemic has had a negative effect on drug discovery, manufacturing, and delivery, as well as on the companies of numerous healthcare firms around the world. The pandemic has resulted in the closing of industrial establishments, with the exception of those that manufacture vital goods, as well as disruptions in product supply chains.
As a result, the COVID-19 pandemic has had three major effects on the economy: 1) immediate effects on supply and demand; 2) disruptions in distribution channels; and 3) financial impact on businesses and financial markets.
Supply chains and industrial operations in India, China, the U.S., and other countries have been affected due to the lockdown, whereas countries such as Thailand, Indonesia, and Singapore are facing issues with medication and medical device transportation.
However, the global cervical cancer diagnostic tests market is expected to be hampered by the effects of the coronavirus (COVID-19) pandemic over the forecast period.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/cervical-cancer-diagnostic-tests-market-3263
Restraint
HPV is the most common cause of cervical cancer. The development of HPV vaccines and the vaccination of females in emerging economies, the U.S., has greatly reduced the risk of HPV infection and, as a result, the incidence of cervical cancer, which is expected to hamper the global cervical cancer diagnostic tests market growth.
Furthermore, rising approvals of HPV vaccines by regulatory bodies is expected to hamper the growth of global cervical cancer diagnostic tests market. For instance, in 2016, the China Food and Drug Administration (CFDA) approved Cervarix as the first HPV vaccine licensed for use in China against cervical cancer to meet the unmet needs of prevention of cervical cancers among Chinese population.
Key Players
Key players are dominating in the global cervical cancer diagnostic tests market are Abbott Laboratories, DYSIS Medical Ltd., Becton, The Cooper Companies, Inc., Dickinson and Company, Danaher Corporation, Quest Diagnostics, F. Hoffmann-La Roche AG, Arbor Vita Corporation, Zilico Ltd, Qiagen and Hologic, Inc.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837